A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

November 2, 2023

Study Completion Date

November 2, 2023

Conditions
Seasonal Allergic Conjunctivitis
Interventions
DRUG

Epinastine Hcl Oph Soln+Simulating Azelastine Hcl Oph Soln

Epinastine Hydrochloride Eye Drops + Simulating Azelastine Hydrochloride Eye Drops are used: both eyes are administered twice daily, once in the morning and once in the evening, with an interval of 8-12 hours between administrations; each time, 1 drop of each of the two eye drops is placed in each eye into the conjunctiva, and the two eye drops are applied at intervals of more than 5 minutes.

DRUG

Azelastine Hcl Oph Sol+Simulating Epinastine Hcl Oph Soln

Azelastine Hydrochloride Eye Drops + Simulating Epinastine Hydrochloride Eye Drops are used: both eyes are administered twice daily, once in the morning and once in the evening, with an interval of 8-12 hours between administrations; each time, 1 drop of each of the two eye drops is placed in each eye into the conjunctiva, and the two eye drops are applied at intervals of more than 5 minutes.

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY